146 related articles for article (PubMed ID: 34789639)
41. Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress.
Xu M; Qi Q; Men L; Wang S; Li M; Xiao M; Chen X; Wang S; Wang G; Jia H; Liu C
Vascul Pharmacol; 2020 Apr; 127():106660. PubMed ID: 32070767
[TBL] [Abstract][Full Text] [Related]
42. Coronary manifestations of Kawasaki Disease in computed tomography coronary angiography.
Goh YG; Ong CC; Tan G; Liang CR; Soomar SM; Terence Lim CW; Quek SC; Teo LSL
J Cardiovasc Comput Tomogr; 2018; 12(4):275-280. PubMed ID: 29426687
[TBL] [Abstract][Full Text] [Related]
43. [Kawasaki disease and atherosclerosis].
Niboshi A; Ozawa S; Hamaoka K
Nihon Rinsho; 2008 Feb; 66(2):387-92. PubMed ID: 18265460
[TBL] [Abstract][Full Text] [Related]
44. [Coronary artery bypass after Kawasaki disease].
Santos V; Simões AS; Teixeira A; Abecasis M; Loureiro M; Anjos R
Rev Port Cardiol; 2012 Jun; 31(6):433-7. PubMed ID: 22592179
[TBL] [Abstract][Full Text] [Related]
45. Angiographic and intravascular ultrasonographic features of Kawasaki coronary artery disease.
Low KW; Poh KK; Tan HC
Singapore Med J; 2012 May; 53(5):e87-9. PubMed ID: 22584987
[TBL] [Abstract][Full Text] [Related]
46. The Spectrum of Cardiovascular Lesions Requiring Intervention in Adults After Kawasaki Disease.
Gordon JB; Daniels LB; Kahn AM; Jimenez-Fernandez S; Vejar M; Numano F; Burns JC
JACC Cardiovasc Interv; 2016 Apr; 9(7):687-96. PubMed ID: 27056307
[TBL] [Abstract][Full Text] [Related]
47. M1 macrophage is the predominant phenotype in coronary artery lesions following Kawasaki disease.
Ohashi R; Fukazawa R; Shimizu A; Ogawa S; Ochi M; Nitta T; Itoh Y
Vasc Med; 2019 Dec; 24(6):484-492. PubMed ID: 31621532
[TBL] [Abstract][Full Text] [Related]
48. Clinical manifestations of coronary aneurysms in the adult as possible sequelae of Kawasaki disease during infancy.
Parisi Q; Abbate A; Biondi-Zoccai GG; Spina D; Savino M; Burzotta F
Acta Cardiol; 2004 Feb; 59(1):5-9. PubMed ID: 15030128
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease.
Suzuki A; Miyagawa-Tomita S; Komatsu K; Nakazawa M; Fukaya T; Baba K; Yutani C
Pediatr Int; 2004 Oct; 46(5):590-6. PubMed ID: 15491390
[TBL] [Abstract][Full Text] [Related]
50. iTRAQ Proteomics Identified the Potential Biomarkers of Coronary Artery Lesion in Kawasaki Disease and In Vitro Studies Demonstrated That S100A4 Treatment Made HCAECs More Susceptible to Neutrophil Infiltration.
Weng KP; Chien KJ; Huang SH; Huang LH; Lin PH; Lin Y; Chang WH; Chen CY; Li SC
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361563
[TBL] [Abstract][Full Text] [Related]
51. [Kawasaki disease: pathological features and sequelae of arteritis].
Tanaka N; Ueno T; Naoe S; Masuda H
Nihon Rinsho; 1983 Sep; 41(9):2008-16. PubMed ID: 6663739
[No Abstract] [Full Text] [Related]
52. A young patient with history of Kawasaki disease presenting with triple vessel disease.
Lim AL; Lam HY; Kareem BA; Kamarulzaman MH
Med J Malaysia; 2012 Apr; 67(2):219-21. PubMed ID: 22822650
[TBL] [Abstract][Full Text] [Related]
53. Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings.
Suzuki A; Miyagawa-Tomita S; Nakazawa M; Yutani C
Jpn Heart J; 2000 May; 41(3):245-56. PubMed ID: 10987345
[TBL] [Abstract][Full Text] [Related]
54. Myocardial infarction in a young adult due to Kawasaki disease. A case report and review of the late cardiological sequelae of Kawasaki disease.
Shaukat N; Ashraf S; Mebewu A; Freemont A; Keenan D
Int J Cardiol; 1993 Jun; 39(3):222-6. PubMed ID: 8335415
[TBL] [Abstract][Full Text] [Related]
55. Utilization of Coronary Artery to Aorta for the Early Detection of Kawasaki Disease.
Na JH; Kim S; Eun LY
Pediatr Cardiol; 2019 Mar; 40(3):461-467. PubMed ID: 30218119
[TBL] [Abstract][Full Text] [Related]
56. Noninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki disease.
Cicala S; Pellegrino T; Storto G; Caprio MG; Paladini R; Mainolfi C; de Leva F; Cuocolo A
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2249-55. PubMed ID: 20680267
[TBL] [Abstract][Full Text] [Related]
57. Coronary artery bypass grafting for an adult with coronary disease due to Kawasaki disease.
Matsuyama K; Ueda Y; Ogino H; Sugita T; Sakakibara Y; Matsubayashi K; Nomoto T
Ann Thorac Cardiovasc Surg; 1998 Jun; 4(3):159-61. PubMed ID: 9660915
[TBL] [Abstract][Full Text] [Related]
58. Cardiac surgical procedures for the coronary sequelae of Kawasaki disease.
Yuan SM
Libyan J Med; 2012; 7():19796. PubMed ID: 23226165
[TBL] [Abstract][Full Text] [Related]
59. Kawasaki disease. With particular emphasis on arterial lesions.
Naoe S; Takahashi K; Masuda H; Tanaka N
Acta Pathol Jpn; 1991 Nov; 41(11):785-97. PubMed ID: 1785339
[TBL] [Abstract][Full Text] [Related]
60. Silent myocardial ischemia in Kawasaki disease: evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing.
Ogawa S; Fukazawa R; Ohkubo T; Zhang J; Takechi N; Kuramochi Y; Hino Y; Jimbo O; Katsube Y; Kamisago M; Genma Y; Yamamoto M
Circulation; 1997 Nov; 96(10):3384-9. PubMed ID: 9396431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
